When selecting partners, meeting stringent sustainability criteria along entire pharmaceutical supply chains has far-reaching environmental, economic and reputational benefits. Whilst adding a sustainability criteria to the bidding process is a positive one for driving more responsible operations across the entire pharmaceutical industry, it simultaneously amplifies the complexity of selecting a Contract Manufacturing Organization (CMO).
Unlock the report to delve into vital statistics and expert insights, covering:
Topped up with expert commentary from industry leaders: Philip Coetzee, Director CMO Management, Daiichi Sankyo and Gregory Vanderwinden, Associate Director – External Manufacturing EU, MSD.
Elevate your CMO selection process and lead the way towards a greener, more sustainable pharmaceutical future. Access the report now.
Please note: That all fields marked with an asterisk (*) are required.